Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Cloning And Mutagenesis Market Set To Climb From $4.21 Billion In 2026 To $8.5 Billion By 2030#_x000D_
The market for cloning and mutagenesis has seen significant growth in recent years. This market is expected to increase from $3.54 billion in 2025 to $4.21 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 19.1%. The expansion observed in prior periods can be attributed to a rise in academic research funding, the increasing scope of recombinant protein research, broader utilization of genetic engineering tools, the widespread availability of standardized molecular biology kits, and a surge in new biotech company activities._x000D_
_x000D_
The cloning and mutagenesis market size is anticipated to expand rapidly over the next few years, reaching $8.5 billion in 2030 at a compound annual growth rate (CAGR) of 19.2%. This expansion during the forecast period is driven by factors such as an escalating demand for gene function investigations, the broadening of synthetic biology applications, increasing capital allocation towards therapeutic protein development, the wider adoption of automated laboratory platforms, and a heightened emphasis on precision genome editing. Key trends expected in this period include the rising uptake of high-fidelity cloning kits, an increased utilization of site-directed mutagenesis techniques, a growing requirement for CRISPR-based editing instruments, the proliferation of automated molecular biology workflows, and an enhanced focus on ensuring reproducibility and accuracy._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Cloning And Mutagenesis Market Growth Drivers: What’s Behind The Acceleration?#_x000D_
The escalating demand for personalized medicine is projected to stimulate the growth of the Cloning And Mutagenesis market in the coming years. Personalized medicine represents an innovative healthcare methodology that customizes medical treatments and interventions to align with the distinct characteristics of each individual patient. Cloning And Mutagenesis contributes significantly across several key areas for personalized therapies, such as disease modeling, drug development, target identification, gene therapy, biomarker discovery, patient-specific cell therapies, pharmacogenomics, and genome editing. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, which was a notable increase from the 6 approvals documented in 2022. Thus, the rising interest in personalized medicine is actively propelling the expansion of the Cloning And Mutagenesis industry._x000D_
_x000D_
#Cloning And Mutagenesis Market Segment Analysis: What Are The Core Market Categories?#_x000D_
The cloning and mutagenesis market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Cloning Kits, Mutagenesis Kits, Other Products_x000D_
2) By Technique: Blunt End Cloning, Topo PCR Cloning, Seamless Cloning, Site-Directed Mutagenesis, Other Techniques_x000D_
3) By End User: Academic and Research Institutes, Biotechnology Companies, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Cloning Kits: Bacterial Cloning Kits, Yeast Cloning Kits, Viral Cloning Kits, Plasmid Cloning Kits_x000D_
2) By Mutagenesis Kits: Site-Directed Mutagenesis Kits, Random Mutagenesis Kits, Error-Prone PCR Kits, CRISPR Or Cas9 Mutagenesis Kits_x000D_
3) By Other Products: Enzymes, Vector Systems, Accessories_x000D_
_x000D_
_x000D_
#Cloning And Mutagenesis Market Trends: What’s Defining The Industry’s Next Phase?#_x000D_
Leading companies in the cloning and mutagenesis markets are actively pursuing advanced methodologies, such as PCR techniques, to gain a competitive advantage. Polymerase chain reaction is a laboratory method utilized in molecular biology to produce multiple copies of a specific DNA segment. For example, in April 2023, Bio-Rad Laboratories, Inc., a US-based biotechnology firm, introduced the ID-Check Speciation Solution, a real-time PCR approach for identifying meat species. This solution enables the identification of animal species in food, feed, and environmental samples, providing a reliable and rapid means to verify raw material origins and optimize production line cleaning processes. It targets mitochondrial DNA from various meat species, including bovine, chicken, duck, goat, horse, sheep, swine, and turkey, demonstrating exceptional sensitivity and the capability to detect as low as 0.001% of the species DNA. The kit also includes a duplex detection system for improved accuracy and simplicity of use._x000D_
_x000D_
#Cloning And Mutagenesis Market Company Landscape And Competitive Strategy#_x000D_
Major companies operating in the cloning and mutagenesis market are Thermo Fisher Scientific Inc, Takara Bio Inc, Agilent Technologies Inc, New England Biolabs Inc, Merck KGaA, Promega Corporation, Bio-Rad Laboratories Inc, GenScript Biotech Corporation, Codex DNA Inc, Integrated DNA Technologies Inc, Bio-Techne Corporation, Sino Biological Inc, OriGene Technologies Inc, Bioneer Corporation, Lucigen Corporation, Inscripta Inc, Creative Biogene, Biomatik Corporation, TransGen Biotech Co Ltd, Jena Bioscience GmbH, EZBioscience, Synbio Technologies LLC _x000D_
_x000D_
#View The Full Cloning And Mutagenesis Market Report:#_x000D_
_x000D_
#Cloning And Mutagenesis Market Largest Region: Which Geography Holds The Highest Market Share?#_x000D_
North America was the largest region in the cloning and mutagenesis market in 2025. Asia-pacific is expected to be the fastest-growing region in the global cloning and mutagenesis market report during the forecast period. The regions covered in the cloning and mutagenesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.